Scientists have long worried about the potential pandemic threat posed by the virus. Three humans in the U.S. have been infected during the current outbreak.
(Bloomberg) -- Moderna Inc. secured nearly $200 million from the US government to speed development of an mRNA vaccine for pandemic influenza as a dangerous strain of bird flu sweeps through the nation’s dairy farms, fueling concern about a budding health crisis. Most Read from BloombergDemocrats Weigh Mid-July Vote to Formally Tap Biden as NomineeTrump Immunity Ruling Means Any Trial Before Election UnlikelyBeryl Becomes Earliest Ever Category 5 Hurricane in Atlantic‘Upflation’ Is the Latest Re
If approved, the RSV vaccine will be Moderna's (MRNA) second approved product in the European Union.